2021 American Transplant Congress
Living Organ Donor Perspectives on Covid-19 Vaccines
*Purpose: Promoting widespread COVID-19 vaccinations is a crucial strategy to protect living organ donors and transplant recipients during the pandemic. We examined perspectives and sources…2021 American Transplant Congress
Covid-19 Infections Post-liver and Kidney Transplantation in a Southern Ca Program
*Purpose: Southern CA is at the epicenter of the Covid-19 pandemic. We reviewed outcomes of our center's liver, kidney, and pancreas transplant patients stricken with…2021 American Transplant Congress
A Mechanistic Evaluation to Guide the Optimal Immunosuppression Adjustment Strategy in Transplant Patients with COVID-19
*Purpose: The optimal management of immunosuppression in transplant patients infected with COVID-19 is unknown. Reduction in calcineurin inhibitors or antimetabolite doses is often performed in…2021 American Transplant Congress
Sars-cov-2 Stat Testing for Organ Donation; One Laboratory’s Experience
*Purpose: The COVID-19 pandemic took the U.S. by storm. The Transplant Community had to navigate through unprecedented scenarios in order to continue the life-saving mission…2021 American Transplant Congress
Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients
*Purpose: Bamlanivimab and casirivimab-imdevimab are authorized for emergency use treatment of mild-to-moderate COVID-19 in patients at high-risk for progression to severe disease or hospitalization. For…2021 American Transplant Congress
Covid-19 Severity within One Year of Liver, Pancreas and Kidney Transplantation
Solid Organ Transplant Surgery, University of Minnesota, Minneapolis, MN
*Purpose: The current pandemic has created uncertainty in the severity of COVID-19 in transplant recipients, especially those given lymphocyte depleting therapy within a year prior…2021 American Transplant Congress
Reduction in Hospitalizations and Deaths in Covid-19 Positive Abdominal Organ Transplant Recipients Following Implementation of A Protocol for Early Treatment with Bamlanivimab
Abdominal Transplantation, Keck Medical Center of USC, Los Angeles, CA
*Purpose: In December of 2020, our program was identifying up to twenty COVID-19 positive abdominal transplant recipients per week. After seeing our high hospitalization and…2021 American Transplant Congress
Short Term Outcomes in Previously Covid Positive Kidney Transplant Recipients in Pre-vaccine Era
Henry Ford Transplant Institute, Detroit, MI
*Purpose: To study clinical characteristics and short-term outcomes in kidney transplant recipients who were previously infected with SARS-CoV-2*Methods: In this retrospective, single-center case-series, we identified…2021 American Transplant Congress
Mortality in Organ Transplant Recipients with Covid-19 Compared to Non-transplant or Waitlisted Patients: A Meta-analysis
Rhode Island Hospital/Brown University, Providence, RI
*Purpose: Organ transplant recipients (OTR) are considered at high risk for adverse outcomes from COVID-19. However, mortality rates range from 30%. Some studies found that…2021 American Transplant Congress
Kidney Transplantation in Times of Covid-19 – Decision Analysis in the Canadian Context
*Purpose: The coronavirus disease 2019 (COVID-19) pandemic significantly impacted the field of transplantation across Canada. In this study, we outline the implications of COVID-19 related…
American Transplant Congress abstracts